share_log

4 Stocks Under $2 Insiders Are Aggressively Buying

4 Stocks Under $2 Insiders Are Aggressively Buying

4 只低于 2 美元的股票内部人士正在积极买入
Benzinga Real-time News ·  2022/04/28 08:20

US crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades.

周四上午,美国原油期货走低。同时,投资者将注意力集中在一些值得注意的内幕交易上。

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

当内部人士购买或出售股票时,这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将其视为影响其整体投资或交易决策的一个因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是近期一些值得注意的细价股内幕交易。欲了解更多信息,请访问本辛加的内幕交易平台。

Bluejay Diagnostics

蓝鸟诊断

  • The Trade: Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Chief Financial Officer Kenneth Fisher acquired a total of 20,000 shares at an average price of $0.99. To acquire these shares, it cost $19.8 thousand.
  • What's Happening: Bluejay Diagnostics recently posted a Q1 loss of $0.10 per share.
  • What Bluejay Diagnostics Does: Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide convenience, timeliness, compliance and low cost to physicians and patients in areas where timeliness of the initial triage assessment has a high impact on course of treatment.
  • 交易: 蓝杰诊断公司 (纳斯达克股票代码:BJDX)首席财务官肯尼思·费舍尔共收购了20,000股股票,平均价格为0.99美元。要收购这些股票,需要花费19.8万美元。
  • 发生了什么: Bluejay Diagnostics最近公布第一季度每股亏损0.10美元。
  • 蓝牙诊断的作用: Bluejay Diagnostics Inc开发、制造和销售创新的临床诊断产品,这些产品通过开发即时检测来提高医疗诊断的质量,这些测试在初始分诊评估的及时性对治疗过程有很大影响的地区,为医生和患者提供便利、及时性、合规性和低成本。

Rise Gold

崛起黄金

  • The Trade: Rise Gold Corp. (OTC:RYES) Director Lawrence W. Lepard acquired a total of 216,500 shares at an average price of $0.51. The insider spent around $110.59 thousand to buy those shares.
  • What's Happening: Rise Gold recently reported progress on Idaho-Maryland use permit.
  • What Rise Gold Does: Rise Gold Corp is a mineral exploration stage mining company and its primary asset is a major past producing Idaho-Maryland Gold Mine property near Grass Valley, California, United States.
  • 这笔交易: Rise Gold 公司 (场外交易代码:RYES)董事劳伦斯·勒帕德共收购了216,500股股票,平均价格为0.51美元。知情人士花了大约11.59万美元购买了这些股票。
  • 发生了什么: Rise Gold最近报告了爱达荷州-马里兰州使用许可证的进展。
  • Rise Gold 能做什么: Rise Gold Corp是一家矿产勘探阶段的矿业公司,其主要资产是过去在美国加利福尼亚州格拉斯谷附近生产爱达荷州-马里兰州金矿的主要资产。

Also check this: Executives Buy Around $413M Of 3 Stocks

另请看这个:高管们买入了约4.13亿美元的3只股票

Don't forget to check out our premarket coverage here .

别忘了在这里查看我们的上市前报道。

Augusta Gold

奥古斯塔·金

  • The Trade: Augusta Gold Corp. (OTC:AUGG) Director Augusta Investments Inc acquired a total of 22,500 shares at an average price of $1.14. To acquire these shares, it cost around $25.61 thousand.
  • What's Happening: The company's stock has gained 35% since the start of the year.
  • What Augusta Gold Does: Augusta Gold Corp is an exploration stage company. The company is primarily engaged in the acquisition and exploration of gold properties.
  • 这笔交易: 奥古斯塔黄金公司 (场外交易代码:AUGG)董事奥古斯塔投资公司共收购了22,500股股票,平均价格为1.14美元。收购这些股票的成本约为25.61万美元。
  • 发生了什么:自年初以来,该公司的股票已上涨了35%。
  • 奥古斯塔·戈尔德是做什么的: 奥古斯塔黄金公司是一家处于勘探阶段的公司。该公司主要从事黄金资产的收购和勘探。

Accustem Sciences

Accustem

  • The Trade: Accustem Sciences Inc. (OTC:ACUT) Director Gabriele M Cerrone acquired a total of 9,447 shares at an average price of $1.43. The insider spent $13.49 thousand to buy those shares.
  • What's Happening: AccuStem recently reported a private placement of common stock.
  • What Accustem Sciences Does: Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe.
  • 这笔交易: Accustem科学公司 (场外交易代码:ACUT)董事加布里埃尔·塞罗内共收购了9,447股股票,平均价格为1.43美元。知情人士花了13.49万美元购买了这些股票。
  • 发生了什么: AccuStem最近报告了普通股的私募配售。
  • Accustem Scien: Accustem Sciences Inc是一家生命科学公司,致力于优化全球所有癌症患者的预后。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发